[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.142.219. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
June 19, 2002

When Should Perioperative β-Blockers Be Discontinued?—Reply

Author Affiliations
 

Stephen J.LurieMD, PhD, Senior EditorIndividualAuthor

JAMA. 2002;287(23):3079-3080. doi:10.1001/jama.287.23.3077

In Reply: In response to Drs Silverstein and Tagliente, because Shammash et al1 did not separate patients who had long-term β-blockers discontinued from those who had perioperative β-blockers discontinued, it is indeed unclear what led to mortality in their findings. For example, it is possible that the excess mortality they observed was a result of so-called rebound from β-blockers, removal of the protective effect of perioperatively administered β-blockers, or withdrawal of the protective effect of chronically administered β-blockers.

First Page Preview View Large
First page PDF preview
First page PDF preview
×